Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2024-04-02 2024-04-02
Drug Identification Number 02078600 02078600
Brand name ULTRAVIST 300 ULTRAVIST 300
Common or Proper name IOPROMIDE IOPROMIDE
Company Name BAYER INC BAYER INC
Ingredients IOPROMIDE IOPROMIDE
Strength(s) 62% 62%
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVASCULAR INTRAVASCULAR INTRAVASCULAR INTRAVASCULAR
Packaging size 100mL 100mL
ATC code V08AB V08AB
ATC description X-RAY CONTRAST MEDIA, IODINATED X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2024-02-15 2024-02-15
Actual start date 2024-01-29 2024-01-29
Estimated end date 2024-09-06 2024-09-06
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments